Return to homepagePandemic Pact

Arresting the spread of SARS-CoV-2 on surfaces and in the air using engineered water nanostructures enriched with de novo designed neutralizing peptides and nature derived antimicrobials.

  • Funded by British Society for Antimicrobial Chemotherapy (BSAC)
  • Total publications:1 publications

Grant number: BSAC-COVID-81

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $100,000

  • Funder

    British Society for Antimicrobial Chemotherapy (BSAC)

  • Principal Investigator

    Philip Demokritou

  • Research Location

    United States of America

  • Lead Research Institution

    Harvard T. H. Chan School of Public Health, Boston

  • Research Priority Alignment

    N/A

  • Research Category

    Infection prevention and control

  • Research Subcategory

    Barriers, PPE, environmental, animal and vector control measures

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Inactivating SARS-CoV-2 Surrogates on Surfaces Using Engineered Water Nanostructures Incorporated with Nature Derived Antimicrobials.